{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:10:53Z","timestamp":1793380253063,"version":"4.5.0"},"reference-count":17,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:sec id=\"ab-noi250093-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Patent foramen ovale (PFO) closure decreases recurrent stroke but increases atrial fibrillation (AF). Careful selection of patients in whom PFO is more likely to be the cause of stroke may improve outcomes by avoiding closure in patients unlikely to benefit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi250093-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether the PFO-Associated Stroke Causal Likelihood (PASCAL) classification system identifies who will experience net benefit and net harm from PFO closure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi250093-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This meta-analysis was a secondary analysis of individual participant-level data from the Systematic, Collaborative, PFO Closure Evaluation (SCOPE) consortium meta-analysis, including all 6 randomized trials of transcatheter PFO closure vs antithrombotic therapy alone. Participants were young and middle-aged adults (mean [SD] age, 45 [10] years) with a PFO and an otherwise cryptogenic stroke. The trials were conducted in hospitals in North America, Europe, Australia, Brazil, and South Korea from 2000 to 2017. The current analysis, involving all trial participants, was performed from January to August 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi250093-7\">\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Transcatheter PFO closure plus antithrombotic therapy vs antithrombotic therapy alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi250093-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary efficacy end point was recurrent ischemic stroke. The primary safety end point was first-ever detection of AF beyond the periprocedural period (&amp;amp;gt;45 days after randomization).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi250093-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 6 trials enrolled 3740 patients (1889 who had PFO closure, 1851 who had medical therapy); 2058 patients (55.0%) were male, and 1682 (45.0%) were female. Among patients in all 6 trials, PASCAL classified PFO relatedness to the index stroke as probable in 1382 patients (37.0%), possible in 1811 (48.4%), and unlikely in 547 (14.6%); among the 2967 patients in the 4 trials with broad entry criteria, PASCAL classified PFO relatedness as probable in 860 patients (29.0%), possible in 1565 (52.7%), and unlikely in 543 (18.3%). The reduction in the absolute rate of recurrent ischemic strokes over 5 years was greater than the increase in first-ever detection of AF in the postperiprocedural period as follows: in the probable group, fewer strokes, \u22122.5% (95% CI, \u22124.2% to \u22121.3%) vs more late AF, 1.3% (95% CI, 0.0% to 2.5%), and in the possible group, fewer strokes \u22123.4% (95% CI, \u22125.4% to \u22121.3%) vs more late AF, 1.1% (95% CI, \u22120.5% to 2.6%). Reduction in recurrent ischemic strokes was not observed and increase in first-ever detected postperiprocedural AF was magnified in the unlikely group (more strokes, 0.4%; 95% CI, \u22124.0% to 4.8%, vs more late AF, 4.6%; 95% CI, 0.3% to 8.9%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi250093-10\">\n                    <jats:title>Conclusion and Relevance<\/jats:title>\n                    <jats:p>Among young and middle-aged patients with PFO and otherwise cryptogenic stroke, the PASCAL classification algorithm distinguished the 4 of every 5 patients in the probable and possible groups with net benefit and the 1 of every 5 patients in the unlikely group with net harm from closure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaneurol.2025.5446","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T16:00:33Z","timestamp":1769443233000},"page":"242","source":"Crossref","is-referenced-by-count":8,"title":["Patent Foramen Ovale Closure in Stroke and the PASCAL Classification System"],"prefix":"10.1001","volume":"83","author":[{"given":"Jeffrey L.","family":"Saver","sequence":"first","affiliation":[{"name":"Comprehensive Stroke Center, David Geffen School of Medicine, University of California, Los Angeles"},{"name":"Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Kent","sequence":"additional","affiliation":[{"name":"Predictive Analytics and Comparative Effectiveness Center, Tufts Medical Center\/Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Kasner","sequence":"additional","affiliation":[{"name":"Comprehensive Stroke Center, Department of Neurology, University of Pennsylvania Medical Center, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Koethe","sequence":"additional","affiliation":[{"name":"Predictive Analytics and Comparative Effectiveness Center, Tufts Medical Center\/Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Carroll","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of Colorado, Denver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Chatellier","sequence":"additional","affiliation":[{"name":"Centre d\u2019Investigations Cliniques, Unite de Recherche Clinique, Hopital Europeen Georges\u2013Pompidou, Assistance Publique\u2013Hopitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Furlan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard C.","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"J\u00fcni","sequence":"additional","affiliation":[{"name":"Applied Health Research Centre, University of Oxford, Oxford, United Kingdom"},{"name":"Applied Health Research Centre, Li Ka Shing Knowledge Institute of St Michael\u2019s Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong S.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pil Hyung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Research Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Lefebvre","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Nelson","sequence":"additional","affiliation":[{"name":"Predictive Analytics and Comparative Effectiveness Center, Tufts Medical Center\/Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Mas","sequence":"additional","affiliation":[{"name":"GHU Paris Psychiatrie et Neurosciences, Hopital Sainte-Anne, Departement of Neurology, Institut de Psychiatrie et Neurosciences de Paris, Universite de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich P.","family":"Mattle","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bern University Hospital, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Meier","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Bern University Hospital, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Reisman","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Washington Medical Center, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Smalling","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, UTHealth\/McGovern Medical School, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Sondergaard","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Copenhagen Hospital Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Kwan","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Research Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Thaler","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tufts Medical Center\/Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"22","key":"noi250093r1","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1001\/jama.2021.20956","article-title":"Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke.","volume":"326","author":"Kent","year":"2021","journal-title":"JAMA"},{"issue":"7","key":"noi250093r2","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","article-title":"An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke.","volume":"81","author":"Kent","year":"2013","journal-title":"Neurology"},{"issue":"7","key":"noi250093r3","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1001\/jamaneurol.2020.0458","article-title":"Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke.","volume":"77","author":"Elgendy","year":"2020","journal-title":"JAMA Neurol"},{"issue":"4","key":"noi250093r4","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1177\/23969873241247978","article-title":"European Stroke Organisation (ESO) guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke.","volume":"9","author":"Caso","year":"2024","journal-title":"Eur Stroke J"},{"issue":"16","key":"noi250093r5","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/jama.2015.3656","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.","volume":"313","author":"Stewart","year":"2015","journal-title":"JAMA"},{"issue":"10","key":"noi250093r7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046042","article-title":"Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice.","volume":"7","author":"Stewart","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"noi250093r8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/insr.12214","article-title":"A tutorial on multilevel survival analysis: methods, models and applications.","volume":"85","author":"Austin","year":"2017","journal-title":"Int Stat Rev"},{"issue":"19","key":"noi250093r9","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1002\/sim.8555","article-title":"One-stage individual participant data meta-analysis models for continuous and binary outcomes: comparison of treatment coding options and estimation methods.","volume":"39","author":"Riley","year":"2020","journal-title":"Stat Med"},{"issue":"6","key":"noi250093r10","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1161\/STROKEAHA.117.018153","article-title":"Patent foramen ovale closure versus medical therapy for cryptogenic ischemic stroke: a topical review.","volume":"49","author":"Saver","year":"2018","journal-title":"Stroke"},{"issue":"9","key":"noi250093r11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.034249","article-title":"Atrial fibrillation after patent foramen ovale closure: incidence, pathophysiology, and management.","volume":"13","author":"Apostolos","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"noi250093r12","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1161\/STROKEAHA.120.030293","article-title":"Atrial fibrillation following patent foramen ovale closure: systematic review and meta-analysis of observational studies and clinical trials.","volume":"52","author":"Chen","year":"2021","journal-title":"Stroke"},{"issue":"5","key":"noi250093r13","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1161\/STROKEAHA.120.032453","article-title":"Embolic stroke of undetermined source and patent foramen ovale: risk of paradoxical embolism score validation and atrial fibrillation prediction.","volume":"52","author":"Strambo","year":"2021","journal-title":"Stroke"},{"issue":"6","key":"noi250093r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2025.108306","article-title":"Quantification of patent foramen ovale shunt severity by transesophageal echocardiogram and transcranial doppler in routine clinical practice.","volume":"34","author":"Sun","year":"2025","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"noi250093r16","doi-asserted-by":"publisher","first-page":"k4245","DOI":"10.1136\/bmj.k4245","article-title":"Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects.","volume":"363","author":"Kent","year":"2018","journal-title":"BMJ"},{"key":"noi250093r6","doi-asserted-by":"crossref","unstructured":"Kent? D, Saver? J, Kasner? S, ; Patient-Centered Outcomes Research Institute (PCORI). Evaluating therapies to prevent future stroke in patients with patent foramen ovale-related strokes: the SCOPE Study, 2023. Accessed December 28, 2025. https:\/\/www.pcori.org\/research-results\/2019\/evaluating-therapies-prevent-future-stroke-patients-patent-foramen-ovale-related-strokes-scope-study","DOI":"10.25302\/04.2023.RS.SCOPE2019001"},{"key":"noi250093r14","unstructured":"Institute for Health Metrics and Evaluation. Global Burden of Disease Study 2021 (GBD 2021) disability weights. Accessed December 28, 2025. https:\/\/ghdx.healthdata.org\/record\/ihme-data\/gbd-2021-disability-weights"},{"key":"noi250093r17","unstructured":"International Council for Harmonisation. ICH harmonised guideline: good clinical practice (GCP) E6(R3), 2023. Accessed December 28, 2025. https:\/\/database.ich.org\/sites\/default\/files\/ICH_E6%28R3%29_DraftGuideline_2023_0519.pdf"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2844104\/jamaneurology_saver_2026_oi_250093_1772558978.34919.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T15:00:39Z","timestamp":1773068439000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2844104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2025.5446","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}